NCT04625543 2022-04-26Neoadjuvant Immunotherapy to ESCCQilu Hospital of Shandong UniversityPhase 2 Withdrawn
NCT02272699 2021-03-18Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell CarcinomaPeking UniversityPhase 2/3 Withdrawn